(Q44880241)

7 December 2017

title

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index (English)

1 reference

7 December 2017

1 reference

1 reference

1 reference

1 reference

1 reference

4

Priyanka Bandara

1 reference

7 December 2017

Archana Sud

1

1 reference

7 December 2017

Jason M Hui

2

1 reference

7 December 2017

Geoffrey C Farrell

3

1 reference

7 December 2017

James G Kench

5

1 reference

7 December 2017

Carolyn Fung

6

1 reference

7 December 2017

Rita Lin

7

1 reference

7 December 2017

Dev Samarasinghe

8

1 reference

7 December 2017

Christopher Liddle

9

1 reference

7 December 2017

Geoffrey W McCaughan

10

1 reference

7 December 2017

Jacob George

11

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

39

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

1239-1247

1 reference

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

7 December 2017

cites work

1 reference

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

7 January 2021

Which patients with hepatitis C develop liver complications?

1 reference

7 January 2021

French consensus conference on hepatitis C: screening and treatment

1 reference

7 January 2021

Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C

1 reference

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

Contribution of obesity to hepatitis C-related fibrosis progression

1 reference

7 January 2021

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

1 reference

7 January 2021

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

7 January 2021

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

1 reference

7 January 2021

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

1 reference

7 January 2021

Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis

1 reference

7 January 2021

Complementary and alternative medicine in chronic liver disease

1 reference

7 January 2021

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

1 reference

7 January 2021

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

7 January 2021

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

1 reference

7 January 2021

How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

7 January 2021

High-performance liquid chromatography and fluorometric detection of biologically important thiols, derivatized with ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate (SBD-F)

1 reference

7 January 2021

Determination of plasma α-tocopherol by high-performance liquid chromatography

1 reference

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

7 January 2021

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

1 reference

7 January 2021

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

7 January 2021

Rate of natural disease progression in patients with chronic hepatitis C.

1 reference

7 January 2021

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

1 reference

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

7 January 2021

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

1 reference

7 January 2021

Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats

1 reference

7 January 2021

Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways

1 reference

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

7 January 2021

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

1 reference

7 January 2021

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

1 reference

7 January 2021

Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis

1 reference

7 January 2021

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

1 reference

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20207

1 reference

release_hhjd6pbvv5fdheqgflwxehtdee

7 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hhjd6pbvv5fdheqgflwxehtdee

24 November 2022

mapped directly with Wikidata item

1 reference